Division of Aging Biology
The Division of Aging Biology (DAB) promotes and supports research and training on the molecular, genetic, cellular, and physiological mechanisms underlying aging and age-related changes in humans and other organisms across numerous phyla. The division has three branches — Cell Biology, Aging Physiology, and Translational Research, all of which function under the guidance of the Office of the Division Director. Support is provided for basic, applied, and translational research into mechanisms of aging from cell-autonomous actions, organelle interactions, interorgan communication, and microbiomes. These studies should uncover shared and species-specific features of aging that will lead to better identification and understanding of key biological processes that determine rates and heterogeneity of aging, and how external factors impact rates of aging. There is special emphasis for research on heterogeneity as a biological driver of divergence in health outcomes (health disparities). Geroscience research is supported to examine diverse mechanisms of interventions that impact rates of aging and health outcomes. The DAB also oversees contracts providing select biological resources for aging research.
Information about DAB programs, and staff contacts for your research.
See a list of current funding opportunities from DAB.
News and announcements from the Division of Aging Biology.
Find biological resources and datasets managed by the Division of Aging Biology
Read about DAB’s small business grants for research and development of new ways to further the understanding of the biology of aging.
The Nathan Shock Centers provide leadership in the pursuit of basic research into the biology of aging.
Find agendas and reports from past DAB workshops.
Read about the new field at the intersection between aging and disease.
Learn more about innovative NIH Common Fund programs related to the biology of aging.
The ITP provides preliminary data on interventions to promote healthy aging in people.
A multi-institutional study of pharmacological interventions to extend lifespan or healthspan in Caenorhabditis.
Read about the NIA-supported Dog Aging Project.